NLM Logo

bococizumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
bococizumab
Unique ID
C000598888
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000598888
Entry Term(s)
PF-04950615
RN-316
RN316
RN316 antibody
Pharm Action
Anticholesteremic Agents
Registry Number
45M75JVK38
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
41
Note
targets proprotein convertase subtilisin/kexin type 9 (PCSK9) for treatment of hypercholesterolemia; in phase 3 clinical trials (2015)
Source
Am J Cardiol. 2015 May 1;115(9):1212-21.
Date of Entry
2015/06/24
Revision Date
2019/10/31
bococizumab Preferred
PF-04950615 Narrower
RN316 Narrower
page delivered in 0.013s